- Report
- October 2024
- 185 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 128 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- July 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- October 2024
- 155 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- June 2024
- 320 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- April 2024
- 117 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2023
- 88 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- June 2022
- 86 Pages
Global
From €3500EUR$3,944USD£3,043GBP
The Enteric Capsule market is a segment of the Medical Devices industry that focuses on the development and production of capsules that are designed to be ingested and pass through the stomach to the small intestine. These capsules are used to deliver drugs, vitamins, and other substances directly to the small intestine, bypassing the stomach and its digestive enzymes. Enteric capsules are typically made of a polymer material that is resistant to the acidic environment of the stomach, allowing them to pass through to the small intestine.
Enteric capsules are used in a variety of medical applications, including the delivery of drugs, vitamins, and other substances to the small intestine. They are also used to deliver drugs to specific areas of the gastrointestinal tract, such as the colon or small intestine.
Enteric capsules are becoming increasingly popular due to their ability to deliver drugs and other substances directly to the small intestine, bypassing the stomach and its digestive enzymes. This allows for more precise and targeted delivery of drugs and other substances, resulting in improved efficacy and fewer side effects.
Some companies in the Enteric Capsule market include Capsugel, EuroCaps, and CapsCanada. Show Less Read more